Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elizabeth A Brem
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
176 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Tower Cancer Research Foundation
Beverly Hills, California, United States
- Uc Irvine Health Cancer Center-Newport
Costa Mesa, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente South Bay
Harbor City, California, United States
- City of Hope Seacliff
Huntington Beach, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- City of Hope at Long Beach Elm
Long Beach, California, United States
- Tibor Rubin Va Medical Center
Long Beach, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente West Los Angeles
Los Angeles, California, United States
- City of Hope Newport Beach
Newport Beach, California, United States
- Kaiser Permanente-Ontario
Ontario, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Ucsf Cancer Center - San Mateo
San Mateo, California, United States
- City of Hope South Pasadena
South Pasadena, California, United States
- City of Hope South Bay
Torrance, California, United States
- City of Hope Upland
Upland, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- Lutheran Hospital - Cancer Centers of Colorado
Golden, Colorado, United States
- Delaware Clinical and Laboratory Physicians Pa
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 May 2021
- Primary completion
- 1 Mar 2027
- Completion
- 1 Mar 2027
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 422
- Registry id
- NCT04799275
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.